4D Molecular director granted 50,000 stock options
4D Molecular Therapeutics director Jacob Chacko received a new stock option grant covering 50,000 shares of common stock.
Rhea-AI Filing Summary
4D Molecular Therapeutics director Jacob Chacko received a new stock option grant covering 50,000 shares of common stock. The option has an exercise price of $9.42 per share and expires on June 16, 2036. It was granted automatically under the company’s non-employee director compensation program.
The option vests as to one-third of the shares on June 17, 2027, then in equal monthly installments until fully vested on June 17, 2029, contingent on his continued service. The award will also vest in full upon a Change in Control as defined in the 2020 Incentive Award Plan. Following this grant, he holds options for 50,000 shares directly.
Insider Trade Summary
Grant/Award: 50,000 shares
Grant/Award
1 txn
Insider
Chacko Jacob
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 50,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 50,000 contracts (Direct)
Footnotes (2)
- F1. Automatically granted pursuant to the terms of the Company's non-employee director compensation program.
- F2. The stock option vests and becomes exercisable with respect to 1/3 of the total shares on June 17, 2027 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on June 17, 2029. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).
Key Figures
Stock options granted: 50,000 options
Exercise price: $9.42 per share
Expiration date: June 16, 2036
+2 more
5 metrics
Stock options granted
50,000 options
Director grant reported on Form 4
Exercise price
$9.42 per share
Strike price of stock option grant
Expiration date
June 16, 2036
Option term end date
Initial vesting date
June 17, 2027
One-third of options vest
Full vesting date
June 17, 2029
Options fully vested if service continues
Key Terms
non-employee director compensation program, stock option, Change in Control, 2020 Incentive Award Plan, +1 more
5 terms
non-employee director compensation program financial
"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."
stock option financial
"The stock option vests and becomes exercisable with respect to 1/3 of the total shares..."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Change in Control financial
"Additionally, the stock options will vest in full upon the consummation of a Change in Control..."
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
2020 Incentive Award Plan financial
"Change in Control (as defined in the 2020 Incentive Award Plan)."
vests and becomes exercisable financial
"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on June 17, 2027..."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did FDMT director Jacob Chacko report in this Form 4 filing?
He reported receiving a stock option grant for 50,000 shares of 4D Molecular Therapeutics common stock. The award is part of the non-employee director compensation program and gives him the right to buy shares at a fixed exercise price.
What is the exercise price of Jacob Chacko’s new FDMT stock options?
The options have an exercise price of $9.42 per share. This is the price he must pay to purchase each share if he exercises the options after they have vested and before they expire.
How do Jacob Chacko’s FDMT stock options vest over time?
One-third of the 50,000 options vest on June 17, 2027. The remaining options vest in equal monthly installments until full vesting on June 17, 2029, assuming he continues serving as a director throughout the vesting period.
When do Jacob Chacko’s FDMT stock options expire?
The options expire on June 16, 2036, if they are not exercised earlier. After this expiration date, any unexercised options will no longer be valid and cannot be used to purchase company shares.
What happens to Jacob Chacko’s FDMT options if there is a Change in Control?
The options will vest in full upon the consummation of a Change in Control, as defined in the company’s 2020 Incentive Award Plan. This means any remaining unvested options become fully exercisable if such a transaction occurs.
How many FDMT options does Jacob Chacko hold after this grant?
After this transaction, he holds options to acquire 50,000 shares of 4D Molecular Therapeutics common stock directly. This Form 4 only reports this specific grant and the resulting derivative holdings from it.
AI-generated analysis. How Rhea-AI works. Not financial advice.
